Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume
Aug 14, 2026
Sale
Shares
321
Price
$500.93
Total Value
$160.80K
Shares Held After
324,443
% of Holdings
0.1%
Aug 14, 2026
Sale
Shares
2,148
Price
$500.05
Total Value
$1.07M
Shares Held After
324,764
% of Holdings
0.7%
Aug 14, 2026
Sale
Shares
3,630
Price
$499.30
Total Value
$1.81M
Shares Held After
326,912
% of Holdings
1.1%
Aug 14, 2026
Sale
Shares
2,130
Price
$498.39
Total Value
$1.06M
Shares Held After
330,542
% of Holdings
0.6%
Aug 14, 2026
Sale
Shares
537
Price
$497.22
Total Value
$267.01K
Shares Held After
332,672
% of Holdings
0.2%
Aug 14, 2026
Sale
Shares
414
Price
$495.96
Total Value
$205.33K
Shares Held After
333,209
% of Holdings
0.1%
Aug 14, 2026
Sale
Shares
320
Price
$495.02
Total Value
$158.41K
Shares Held After
333,623
% of Holdings
0.1%
Aug 14, 2026
Purchase
Shares
115,200
Price
$8.68
Total Value
$999.51K
Shares Held After
300,461
% of Holdings
38.3%
Aug 14, 2026
Sale
Shares
2,273
Price
$57.15
Total Value
$129.90K
Shares Held After
28,058
% of Holdings
7.5%

DEXCOM INC (DXCM)

Brown Michael Jon — EVP Chief Legal Compliance Off
Aug 14, 2026
Sale
Shares
1,700
Price
$91.93
Total Value
$156.28K
Shares Held After
102,953
% of Holdings
1.6%

TELA Bio, Inc. (TELA)

Getz Heather C — Director
Aug 14, 2026
Purchase
Shares
15,000
Price
$0.70
Total Value
$10.47K
Shares Held After
520,000
% of Holdings
2.9%

ZEVRA THERAPEUTICS, INC. (ZVRA)

Thompson Rahsaan — Chief Legal&Compliance
Aug 14, 2026
Sale
Shares
42,666
Price
$11.13
Total Value
$474.77K
Shares Held After
37,569
% of Holdings
53.2%

ARTIVION, INC. (AORT)

GREEN ANDREW M — SVP, Regulatory and Quality
Aug 14, 2026
Sale
Shares
616
Price
$28.55
Total Value
$17.59K
Shares Held After
59,643
% of Holdings
1.0%

ARTIVION, INC. (AORT)

Berry Lance A — EVP, COO, CFO&Treasurer
Aug 14, 2026
Sale
Shares
715
Price
$28.55
Total Value
$20.41K
Shares Held After
210,112
% of Holdings
0.3%

Neuronetics, Inc. (STIM)

Chernett Jorey — 10% Owner
Aug 14, 2026
Purchase
Shares
14,000
Price
$3.16
Total Value
$44.24K
Shares Held After
10,602,988
% of Holdings
0.1%

EDAP TMS SA (EDAP)

Annen Steven — SVP, Marketing&Product Mgmt.
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
136,490
% of Holdings
3.7%

EDAP TMS SA (EDAP)

WILLSEY LANCE — Director
Aug 14, 2026
Purchase
Shares
50,000
Price
$4.75
Total Value
$237.50K
Shares Held After
1,291,780
% of Holdings
3.9%

EDAP TMS SA (EDAP)

Shah Sanket — General Counsel&Corp Sec
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
72,500
% of Holdings
6.9%

EDAP TMS SA (EDAP)

Rhodes Ryan — Director
Aug 14, 2026
Purchase
Shares
21,000
Price
$4.75
Total Value
$99.75K
Shares Held After
626,649
% of Holdings
3.4%

EDAP TMS SA (EDAP)

LEVINE JOSHUA — Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
45,000
% of Holdings
22.2%

EDAP TMS SA (EDAP)

Mobeck Kenneth S. — Chief Financial Officer
Aug 14, 2026
Purchase
Shares
5,000
Price
$4.75
Total Value
$23.75K
Shares Held After
181,610
% of Holdings
2.8%

EDAP TMS SA (EDAP)

Schulz Fran — Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
15,100
% of Holdings
66.2%

EDAP TMS SA (EDAP)

Horn David R. — Director
Aug 14, 2026
Purchase
Shares
10,000
Price
$4.75
Total Value
$47.50K
Shares Held After
10,000
% of Holdings
100.0%
Aug 14, 2026
Sale
Shares
40
Price
$333.23
Total Value
$13.33K
Shares Held After
50,000
% of Holdings
0.1%
Aug 14, 2026
Sale
Shares
3,095
Price
$331.43
Total Value
$1.03M
Shares Held After
50,040
% of Holdings
5.8%
Aug 14, 2026
Sale
Shares
4,896
Price
$330.36
Total Value
$1.62M
Shares Held After
53,135
% of Holdings
8.4%
Aug 14, 2026
Sale
Shares
7,428
Price
$329.60
Total Value
$2.45M
Shares Held After
58,031
% of Holdings
11.3%
Aug 14, 2026
Sale
Shares
1,687
Price
$328.52
Total Value
$554.21K
Shares Held After
65,459
% of Holdings
2.5%
Aug 14, 2026
Sale
Shares
5,226
Price
$327.39
Total Value
$1.71M
Shares Held After
67,146
% of Holdings
7.2%
Aug 14, 2026
Sale
Shares
2,287
Price
$326.60
Total Value
$746.94K
Shares Held After
72,372
% of Holdings
3.1%
Aug 14, 2026
Sale
Shares
341
Price
$325.60
Total Value
$111.03K
Shares Held After
74,659
% of Holdings
0.5%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
3,847
Price
$111.14
Total Value
$427.55K
Shares Held After
31,034
% of Holdings
11.0%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
9,193
Price
$110.00
Total Value
$1.01M
Shares Held After
34,881
% of Holdings
20.9%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
10,200
Price
$109.11
Total Value
$1.11M
Shares Held After
44,074
% of Holdings
18.8%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
14,696
Price
$107.97
Total Value
$1.59M
Shares Held After
54,274
% of Holdings
21.3%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
10,434
Price
$107.14
Total Value
$1.12M
Shares Held After
68,970
% of Holdings
13.1%

Oruka Therapeutics, Inc. (ORKA)

Quinlan Paul T — General Counsel
Aug 14, 2026
Sale
Shares
3,630
Price
$106.05
Total Value
$384.96K
Shares Held After
79,404
% of Holdings
4.4%
Shares
1,800
Price
$0.06
Total Value
$111.60
Shares Held After
9,355,456
% of Holdings
0.0%

AbCellera Biologics Inc. (ABCL)

Booth Andrew — Chief Financial Officer
Aug 14, 2026
Purchase
Shares
37,200
Price
$10.32
Total Value
$383.90K
Shares Held After
482,800
% of Holdings
7.7%
Aug 13, 2026
Sale
Shares
5,250
Price
$7.21
Total Value
$37.85K
Shares Held After
65,936
% of Holdings
7.4%

Medline Inc. (MDLN)

GIC Private Ltd — 10% Owner
Aug 13, 2026
Sale
Shares
1,500,000
Price
$35.80
Total Value
$53.70M
Shares Held After
22,902,482
% of Holdings
6.1%

MDxHealth SA (MDXH)

MVM Partners, LLC — Director
Aug 13, 2026
Purchase
Shares
2,202,643
Price
$0.45
Total Value
$1000.00K
Shares Held After
6,903,100
% of Holdings
31.9%

Dyne Therapeutics, Inc. (DYN)

Friedl-Naderer Johanna — Chief Commercial Officer
Aug 13, 2026
Sale
Shares
226
Price
$26.28
Total Value
$5.94K
Shares Held After
153,982
% of Holdings
0.1%

Cue Biopharma, Inc. (CUE)

Meluzio Michael Vincent — VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
3
Price
$31.13
Total Value
$93.39
Shares Held After
48,961
% of Holdings
0.0%

Cue Biopharma, Inc. (CUE)

Meluzio Michael Vincent — VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
4,106
Price
$30.35
Total Value
$124.62K
Shares Held After
48,964
% of Holdings
7.7%

Cue Biopharma, Inc. (CUE)

Meluzio Michael Vincent — VP, Prin. Accounting Officer
Aug 13, 2026
Sale
Shares
1,519
Price
$29.37
Total Value
$44.61K
Shares Held After
53,070
% of Holdings
2.8%

OMEROS CORP (OMER)

Borges David J. — VP, Finance&CAO
Aug 13, 2026
Sale
Shares
5,000
Price
$16.95
Total Value
$84.75K
Shares Held After
0
% of Holdings
100.0%
Aug 13, 2026
Sale
Shares
175,300
Price
$8.86
Total Value
$1.55M
Shares Held After
4,371,387
% of Holdings
3.9%
Aug 13, 2026
Sale
Shares
500,000
Price
$9.24
Total Value
$4.62M
Shares Held After
11,743,530
% of Holdings
4.1%
Aug 13, 2026
Sale
Shares
215,233
Price
$9.54
Total Value
$2.05M
Shares Held After
12,243,530
% of Holdings
1.7%
Version: v26.7.3